RJFSA
PRCT icon

Raymond James Financial Services Advisors’s Procept Biorobotics PRCT Stock Holding History

Raymond James Financial Services Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$227K Sell
2,832
-11,156
-80% -$793K ﹤0.01% 3114
2024
Q2 		$855K Buy
+13,988
New +$832K ﹤0.01% 2186
2023
Q1 		– Sell
-7,045
Closed -$293K – 3375
2022
Q4 		$293K Buy
7,045
+1,200
+21% +$51.5K ﹤0.01% 2602
2022
Q3 		$242K Buy
+5,845
New +$233K ﹤0.01% 2728

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Raymond James Financial Services Advisors's PRCT Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Procept Biorobotics (PRCT) stake by 80% in Q3 2024, selling an estimated $793K and leaving 2,832 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.

Raymond James Financial Services Advisors first reported a position in PRCT in Q3 2022 and has held it in 4 quarters since. The position peaked at $855K in Q2 2024. 250 funds tracked by Wall St. Rank hold PRCT as of Q3 2024.

  • Raymond James Financial Services Advisors held 2,832 shares of Procept Biorobotics worth $227K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 11,156 Procept Biorobotics shares in Q3 2024, an estimated $793K.
  • Procept Biorobotics made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3114 holding.
  • Raymond James Financial Services Advisors first reported a position in Procept Biorobotics in Q3 2022 and has held it in 4 quarters since.
  • Raymond James Financial Services Advisors's Procept Biorobotics position peaked at $855K in Q2 2024.
  • 250 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.